Clinical Trials on Bone Metastases in Men With Hormone-Refractory Prostate Cancer in Singapore
Total 3 results
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
National University Hospital, SingaporeCompletedHormone-Refractory Prostate CancerSingapore
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany